Kisor DF[au] - Search Results

Year	Number of Results
1989	1
1990	2
1992	2
1993	3
1996	3
1997	1
1998	1
1999	1
2000	1
2005	2
2006	2
2007	1
2009	1
2010	1
2013	1
2014	2
2015	4
2016	6
2017	5
2018	6
2019	3
2020	1
2021	5
2022	2
2023	3

1

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.

Lee CR, Luzum JA, Sangkuhl K, Gammal RS, Sabatine MS, Stein CM, Kisor DF, Limdi NA, Lee YM, Scott SA, Hulot JS, Roden DM, Gaedigk A, Caudle KE, Klein TE, Johnson JA, Shuldiner AR. Lee CR, et al. Among authors: kisor df. Clin Pharmacol Ther. 2022 Nov;112(5):959-967. doi: 10.1002/cpt.2526. Epub 2022 Feb 8. Clin Pharmacol Ther. 2022. PMID: 35034351 Review.

2

Beyond the didactic lecture: pharmacogenomics in pharmacy education.

Kisor DF, Calinski DM, Farrell CL. Kisor DF, et al. Per Med. 2018 Jan;15(1):9-12. doi: 10.2217/pme-2017-0056. Per Med. 2018. PMID: 29714112 No abstract available.

3

Advancing Pharmacogenomics-Based Care Through Interprofessional Education.

Lee YM, Berenbrok LA, Gálvez-Peralta M, Iwuchukwu O, Kisor DF, Petry NJ, Gammal RS. Lee YM, et al. Among authors: kisor df. Am J Pharm Educ. 2023 May;87(5):100007. doi: 10.1016/j.ajpe.2022.10.001. Epub 2023 Mar 15. Am J Pharm Educ. 2023. PMID: 37288681

4

The Expanded Potential Role of Pharmacogenomics.

Kisor DF. Kisor DF. Sr Care Pharm. 2021 Jun 1;36(6):270-272. doi: 10.4140/TCP.n.2021.270. Sr Care Pharm. 2021. PMID: 34016223

5

Nelarabine use in leukemias.

Kisor DF. Kisor DF. Drugs Today (Barc). 2006 Jul;42(7):455-65. doi: 10.1358/dot.2006.42.7.985638. Drugs Today (Barc). 2006. PMID: 16894400 Review.

6

Pharmacogenetic associations and evidence-based pharmacogenomics guidelines: supporting label and off-label use of drug-gene interaction data.

Kisor DF, Monte AA, Müller DJ. Kisor DF, et al. Pharmacogenomics. 2020 May;21(7):427-430. doi: 10.2217/pgs-2020-0017. Epub 2020 Apr 22. Pharmacogenomics. 2020. PMID: 32319356 No abstract available.

7

Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.

Beam TA, Loudermilk EF, Kisor DF. Beam TA, et al. Among authors: kisor df. Physiol Genomics. 2017 Feb 1;49(2):81-87. doi: 10.1152/physiolgenomics.00126.2016. Epub 2016 Dec 23. Physiol Genomics. 2017. PMID: 28011884 Review.

8

Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example.

Kisor DF, Petry NJ, Bright DR. Kisor DF, et al. Pharmgenomics Pers Med. 2021 May 18;14:569-577. doi: 10.2147/PGPM.S224894. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 34040417 Free PMC article. Review.

9

Educational strategies to enable expansion of pharmacogenomics-based care.

Weitzel KW, Aquilante CL, Johnson S, Kisor DF, Empey PE. Weitzel KW, et al. Among authors: kisor df. Am J Health Syst Pharm. 2016 Dec 1;73(23):1986-1998. doi: 10.2146/ajhp160104. Am J Health Syst Pharm. 2016. PMID: 27864206 Free PMC article. Review.

10

Genetic Variants Associated With Opioid Use Disorder.

Freiermuth CE, Kisor DF, Lambert J, Braun R, Frey JA, Bachmann DJ, Bischof JJ, Lyons MS, Pantalon MV, Punches BE, Ancona R, Sprague JE. Freiermuth CE, et al. Among authors: kisor df. Clin Pharmacol Ther. 2023 May;113(5):1089-1095. doi: 10.1002/cpt.2864. Epub 2023 Feb 19. Clin Pharmacol Ther. 2023. PMID: 36744646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

55 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year